Cytisinicline could offer adult cigarette smokers a potential new treatment option

FHS
July 11, 2023
11:23 pm

The first large-scale U.S. clinical trial of cytisinicline, led by a Massachusetts General Hospital (MGH) investigator, found the smoking cessation medication to be effective and well tolerated in adults who wished to break their nicotine dependence.

Vicarious presses forward with soft tissue robot despite struggles

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Vicarious Surgical is pushing ahead

March 6, 2024

Real-world data reveals factors associated with long-term weight loss in obesity

A Cleveland Clinic study identified key factors that can impact the long-term weight loss of patients with obesity who were prescribed injectable semaglutide or liraglutide

September 14, 2024

AstraZeneca-Daiichi Sankyo’s gastric cancer therapy approved

AstraZeneca and Daiichi Sankyo’s Enhertu achieved a confirmed ORR of 28.8% and a median PFS of 5.7 months. Credit: Robert Way/Shutterstock. AstraZeneca and Daiichi Sankyo‘s

August 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.